First Time Loading...

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Watchlist
Price: 32.62 CNY -0.24% Market Closed
Updated: May 18, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

78.6B
+6%
Assets
Growth Rates:
1 Year
+5%
3 Years
+32%
5 Years
+53%
7 Years
+203%
10 Years
+542%
43.7B
+10%
Liabilities
Growth Rates:
1 Year
+3%
3 Years
+30%
5 Years
+47%
7 Years
+411%
10 Years
+706%
34.9B
+0.7%
Equity
Growth Rates:
1 Year
+9%
3 Years
+34%
5 Years
+61%
7 Years
+101%
10 Years
+411%

Balance Sheet Decomposition
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

78.6B
Assets
43.7B
Liabilities
78.6B
Assets
43.7B
Liabilities
Current Assets 56B
Cash & Short-Term Investments 20.6B
Receivables 21.5B
Other Current Assets 13.9B
Non-Current Assets 22.6B
Long-Term Investments 9.6B
PP&E 7.5B
Intangibles 4B
Other Non-Current Assets 1.4B
Current Liabilities 36.2B
Accounts Payable 11.8B
Accrued Liabilities 2.8B
Short-Term Debt 11.7B
Other Current Liabilities 10B
Non-Current Liabilities 7.4B
Long-Term Debt 3.9B
Other Non-Current Liabilities 3.5B

Balance Sheet
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
3 313
4 167
13 091
11 697
16 115
18 470
17 765
21 013
20 805
19 824
Cash
7
6
1
1
1
1
1
20 946
20 805
19 824
Cash Equivalents
3 306
4 161
13 090
11 696
16 114
18 469
17 764
67
0
0
Short-Term Investments
5
6
26
1 861
1 542
41
54
0
2 174
733
Total Receivables
2 662
2 769
3 061
3 773
15 229
17 216
17 015
19 175
20 652
21 526
Accounts Receivables
1 006
1 052
1 108
1 114
10 872
12 555
12 390
12 817
14 858
15 112
Other Receivables
1 656
1 717
1 953
2 659
4 357
4 661
4 625
6 358
5 795
6 414
Inventory
2 579
2 544
2 781
3 700
9 232
9 490
9 765
10 438
10 672
11 507
Other Current Assets
330
319
555
473
914
765
2 798
2 185
2 762
2 394
Total Current Assets
8 889
9 805
19 514
21 505
43 031
45 982
47 397
52 811
57 064
55 984
PP&E Net
2 266
2 490
2 362
2 367
3 646
4 726
5 260
5 836
6 570
7 516
PP&E Gross
2 266
2 490
2 362
2 367
3 646
4 726
5 260
5 836
6 570
7 516
Accumulated Depreciation
1 998
2 168
2 214
2 326
2 982
3 419
3 823
4 159
4 664
5 059
Intangible Assets
399
546
671
729
1 013
2 487
2 450
2 593
2 826
3 196
Goodwill
0
2
11
11
826
826
826
829
829
829
Long-Term Investments
2 320
2 674
2 847
3 265
2 300
2 162
2 964
3 105
6 104
9 622
Other Long-Term Assets
336
354
491
438
666
711
863
944
1 272
1 440
Other Assets
0
2
11
11
826
826
826
829
829
829
Total Assets
14 211
N/A
15 871
+12%
25 897
+63%
28 315
+9%
51 482
+82%
56 894
+11%
59 760
+5%
66 118
+11%
74 665
+13%
78 587
+5%
Liabilities
Accounts Payable
2 076
2 636
2 267
2 802
9 313
9 699
10 875
11 287
11 200
11 842
Accrued Liabilities
412
413
655
703
1 406
938
927
1 361
2 660
2 778
Short-Term Debt
917
922
346
264
8 562
9 851
11 550
11 905
12 929
11 665
Current Portion of Long-Term Debt
0
0
0
31
204
229
236
246
707
250
Other Current Liabilities
2 657
2 856
4 154
4 469
7 463
8 659
5 655
7 454
9 899
9 700
Total Current Liabilities
6 062
6 828
7 422
8 269
26 949
29 377
29 243
32 254
37 395
36 235
Long-Term Debt
0
40
34
0
522
551
1 059
1 251
2 185
3 902
Deferred Income Tax
15
29
77
115
250
267
286
332
395
640
Minority Interest
220
233
309
392
1 459
1 805
2 060
2 264
1 573
1 759
Other Liabilities
175
289
711
668
618
709
966
955
1 053
1 132
Total Liabilities
6 471
N/A
7 420
+15%
8 552
+15%
9 443
+10%
29 797
+216%
32 709
+10%
33 615
+3%
37 056
+10%
42 600
+15%
43 668
+3%
Equity
Common Stock
1 291
1 291
1 626
1 626
1 626
1 626
1 626
1 626
1 626
1 626
Retained Earnings
6 436
4 814
6 651
7 441
10 195
12 694
14 652
17 497
20 347
23 212
Additional Paid In Capital
0
2 346
9 058
9 875
9 865
9 865
9 885
9 957
10 106
10 106
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
16
30
Other Equity
12
1
10
70
0
0
18
17
3
6
Total Equity
7 739
N/A
8 451
+9%
17 345
+105%
18 872
+9%
21 685
+15%
24 185
+12%
26 145
+8%
29 062
+11%
32 065
+10%
34 919
+9%
Total Liabilities & Equity
14 211
N/A
15 871
+12%
25 897
+63%
28 315
+9%
51 482
+82%
56 894
+11%
59 760
+5%
66 118
+11%
74 665
+13%
78 587
+5%
Shares Outstanding
Common Shares Outstanding
1 291
1 291
1 626
1 626
1 626
1 626
1 626
1 626
1 626
1 626

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.